Cure8 Ventures

Cure8 Ventures is an early-stage venture capital investment firm based in St. Louis, Missouri, founded in 2018. The firm specializes in investing in the food, healthcare, and wellness sectors, focusing on innovative companies that aim to improve quality of life and promote healthier lifestyles. Through its investments, Cure8 Ventures seeks to support the growth of businesses that align with its mission to enhance the food and health landscape.

Justin Siegel

Chief Innovation Officer and Venture Partner

1 past transactions

Exciva

Series A in 2021
exciva is a Provider of targeted drug rescue program intended to involve pharmaceutical research and development based in Heidelberg, Germany. The company's program has been formulated for developing symptomatic and disease-modifying treatments, therapies, cures, prophylactics, supplements, formulations and methods of making and using such compositions, enabling the healthcare industry to access their program for rescuing and reusing approved drugs for new indications and new uses.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.